Participants that finish the intervention
| Group | Value | 95% CI |
|---|---|---|
| Intervention Group | 99 | |
| Control Group | 83 |
Last reviewed · How we verify
Breast Cancer: Feasibility of an Educational Intervention
NA trial testing Precam in Women's Health: Neoplasm of Breast in 224 participants. Completed in 9 November 2020.
| Lead sponsor | University of Oviedo |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 224 |
| Start date | 1 December 2019 |
| Primary completion | 31 January 2020 |
| Estimated completion | 9 November 2020 |
| Sites | 1 location across Spain |
University of Oviedo
Adults 25 to 50, female only, with Women's Health: Neoplasm of Breast. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Participants that finish the intervention
| Group | Value | 95% CI |
|---|---|---|
| Intervention Group | 99 | |
| Control Group | 83 |
People that did not finish the intervention
| Group | Value | 95% CI |
|---|---|---|
| Intervention | 35 | |
| Control | 7 |
Mean number of recommendations done by the participants
| Group | Value | 95% CI |
|---|---|---|
| Intervention Group | 9.38 | ± 1.789 |
| Control Group | 8.28 | ± 2.265 |
Using 2 dimensions of MARA questionnaire (Scale title)1) knowledge of risk factors of breast cancer (range 0=worst score to 9=better score); 2) knowledge of signs and symptoms of breast cancer (range 0=worst score to 9=better score)
| Group | Value | 95% CI |
|---|---|---|
| Intervention | 2.04 | ± 1.531 |
| Control | 1.31 | ± 1.239 |
| Group | Value | 95% CI |
|---|---|---|
| Intervention | 3.61 | ± 0.636 |
| Control | 3.38 | ± 0.809 |
Aim: To evaluate the viability of an educational intervention for the prevention of breast cancer risk and the modification of their risk behaviors through the use of a web application in women living in the Principality of Asturias. Design: pilot test Population: 300 women without breast cancer living in Asturias. 25 to 50 years old. Informed consent signed. Variables: personal characteristics (age, status, educational level, occupation), MIC index, dietary characteristics, level of physical activity, presence of known risks of breast cancer (number of children, breastfeeding, oral contraceptives, family history of cancer, previous cancer, breast density and knowledge related with breast cancer prevention. Intervention: * Intervention Group:6 months intervention using a web-app related with personal care and breast cancer risks, diet and physical activity. * Control Group: no intervention.
1 peer-reviewed publication reference this trial (live from Europe PMC):
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04396665.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing